Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kala Visvanathan

Showing results (81-90 of 297) with videos related to

Pageof 30
Sort By:
Breast Cancer Research and Treatment|May 21, 2011
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profilesAbena S Agyeman, Raghothama Chaerkady, Patrick G Shaw, et al.
JNCI Cancer Spectrum|December 9, 2023
Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studiesM Diana van Die, Kerry M Bone, Kala Visvanathan, et al.
Journal of Cancer Survivorship : Research and Practice|January 27, 2018
Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USALorraine T Dean, Kathryn H Schmitz, Kevin D Frick, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 13, 2023
Comparing Cancer Incidence in an Observational Cohort of Medicaid Beneficiaries With and Without HIV, 2001-2015Jacqueline E Rudolph, Keri L Calkins, Xiaoqiang Xu, et al.
Current Environmental Health Reports|November 13, 2025
Hazardous Environmental Pollutants and Cancer Disparities: A Systematic Review on the Consideration of Race and Ethnicity in Environmental Epidemiology ResearchMolly E Schwalb, Kala Visvanathan, Avonne E Connor, et al.
Journal of the National Cancer Institute|December 21, 2006
Statin drugs and risk of advanced prostate cancerElizabeth A Platz, Michael F Leitzmann, Kala Visvanathan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2011
Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinomaElisabetta Kuhn, Alan K Meeker, Kala Visvanathan, et al.
International Journal of Cancer|September 20, 2018
Circulating sCD27 and sCD30 in pre-diagnostic samples collected fifteen years apart and future non-Hodgkin lymphoma riskMark P Purdue, Qing Lan, Judith Hoffman-Bolton, et al.
Academic Radiology|April 18, 2026
Persistent Delays in Diagnostic Evaluation Timeliness After an Abnormal Screening Mammogram in the Years following the Onset of the COVID-19 PandemicEniola T Oluyemi, Kathryn A Carson, Emily B Ambinder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 11, 2013
Plasma sphingolipids and lung cancer: a population-based, nested case-control studyAnthony J Alberg, Kent Armeson, Jason S Pierce, et al.
Pageof 30

Showing results (81-90 of 297) with videos related to

Sort By:
Pageof 30
Breast Cancer Research and Treatment|May 21, 2011
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profilesAbena S Agyeman, Raghothama Chaerkady, Patrick G Shaw, et al.
JNCI Cancer Spectrum|December 9, 2023
Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studiesM Diana van Die, Kerry M Bone, Kala Visvanathan, et al.
Journal of Cancer Survivorship : Research and Practice|January 27, 2018
Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USALorraine T Dean, Kathryn H Schmitz, Kevin D Frick, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 13, 2023
Comparing Cancer Incidence in an Observational Cohort of Medicaid Beneficiaries With and Without HIV, 2001-2015Jacqueline E Rudolph, Keri L Calkins, Xiaoqiang Xu, et al.
Current Environmental Health Reports|November 13, 2025
Hazardous Environmental Pollutants and Cancer Disparities: A Systematic Review on the Consideration of Race and Ethnicity in Environmental Epidemiology ResearchMolly E Schwalb, Kala Visvanathan, Avonne E Connor, et al.
Journal of the National Cancer Institute|December 21, 2006
Statin drugs and risk of advanced prostate cancerElizabeth A Platz, Michael F Leitzmann, Kala Visvanathan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2011
Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinomaElisabetta Kuhn, Alan K Meeker, Kala Visvanathan, et al.
International Journal of Cancer|September 20, 2018
Circulating sCD27 and sCD30 in pre-diagnostic samples collected fifteen years apart and future non-Hodgkin lymphoma riskMark P Purdue, Qing Lan, Judith Hoffman-Bolton, et al.
Academic Radiology|April 18, 2026
Persistent Delays in Diagnostic Evaluation Timeliness After an Abnormal Screening Mammogram in the Years following the Onset of the COVID-19 PandemicEniola T Oluyemi, Kathryn A Carson, Emily B Ambinder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 11, 2013
Plasma sphingolipids and lung cancer: a population-based, nested case-control studyAnthony J Alberg, Kent Armeson, Jason S Pierce, et al.
Pageof 30